Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1)

The purpose of this study was to evaluate the safety and efficacy of lotilaner ophthalmic solution, 0.25%, compared with vehicle for the treatment of Demodex blepharitis. METHODS: In this prospective, randomized, controlled, double-masked, phase 2b/3 clinical trial, 421 patients with Demodex blephar...

Descripción completa

Detalles Bibliográficos
Autores principales: Yeu, Elizabeth, Wirta, David L., Karpecki, Paul, Baba, Stephanie N., Holdbrook, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cornea 2023
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973441/
https://www.ncbi.nlm.nih.gov/pubmed/35965392
http://dx.doi.org/10.1097/ICO.0000000000003097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973441/
https://www.ncbi.nlm.nih.gov/pubmed/35965392
http://dx.doi.org/10.1097/ICO.0000000000003097

Ejemplares similares